Atlas Trials

NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD

Clinical trial NCT00557011 · COMPLETED

Trial details

NCT number
NCT00557011
Sponsor
New River Pharmaceuticals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Attention Deficit Disorder With Hyperactivity
Start date
2004-09-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.